Agenus Inc. (AJ8)

Profile

https://www.agenusbio.com

Agenus Inc. is a clinical-stage biotechnology company focused on immuno-oncology and the development of therapies designed to activate the immune system against cancer. The company’s current work centers on antibody-based therapeutics, immune checkpoint modulators, cell therapies, vaccines, and vaccine adjuvants, supported by proprietary discovery and manufacturing capabilities. Its pipeline includes programs intended for solid tumors and other difficult-to-treat cancers, with activities spanning research, clinical development, and translational science. Agenus also operates through its subsidiaries and technology platforms to support antibody discovery and cell-therapy development, reflecting a vertically integrated model in biotechnology. Headquartered in Lexington, Massachusetts, and founded in 1994, Agenus serves as a development-stage company within the broader life sciences market, where it contributes to cancer immunotherapy innovation and clinical research.